Suchergebnisse - Java, James J.
- Treffer 1 - 15 von 15
-
1
-
2
Mixed-methods content and sentiment analysis of adolescents’ voice-diaries describing daily experiences with asthma and self-management decision-making von Mammen, Jennifer R., Java, James J., Rhee, Hyekyun, Butz, Arlene M., Halterman, Jill S., Arcoleo, Kimberly
Veröffentlicht 2018Text -
3
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-base... von Rose, Peter G, Java, James J, Whitney, Charles W., Stehman, Frederick B, Lanciano, Rachelle, Thomas, Gillian M
Veröffentlicht 2014Text -
4
The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group tr... von Chan, John K., Java, James J., Fuh, Katherine, Monk, Bradley J., Kapp, Daniel S., Herzog, Thomas, Bell, Jeffrey, Young, Robert
Veröffentlicht 2016Text -
5
Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study von Tewari, Devansu, Java, James J., Salani, Ritu, Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas, Monk, Bradley J., Chan, John K.
Veröffentlicht 2015Text -
6
Disease Extent at Secondary Cytoreductive Surgery is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Grou... von Rose, Peter G., Java, James J., Morgan, Mark A., Secord, Angeles Alvarez, Kesterson, Joshua P., Stehman, Frederick B., Warshal, David P., Creasman, William T., Hanjani, Parviz, Morris, Robert T., Copeland, Larry J.
Veröffentlicht 2016Text -
7
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study von Seamon, Leigh G, Java, James J, Monk, Bradley J, Penson, Richard T, Brown, Jubilee, Mannel, Robert S, Oaknin, Anna, Leitao, Mario M, Eisenhauer, Eric L, Long, Harry J, Liao, Shu Y, Tewari, Krishnansu S
Veröffentlicht 2018Text -
8
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group... von Garcia-Soto, Arlene E, Java, James J, Neira, Wilberto Nieves, Pearson, J Matthew, Cohn, David E., Lele, Shashikant B, Tewari, Krishnansu S, Walker, Joan L, Secord, Angeles Alvarez, Armstrong, Deborah K, Copeland, Larry J
Veröffentlicht 2016Text -
9
Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Stud... von Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O’Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Veröffentlicht 2018Text -
10
Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Onc... von Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O'Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Veröffentlicht 2018Text -
11
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data... von Moore, Kathleen N., Java, James J., Slaughter, Katrina N., Rose, Peter G., Lanciano, Rachelle, DiSilvestro, Paul A., Thigpen, J. Tate, Lee, Yi-Chun, Tewari, Krishnansu S., Chino, Junzo, Seward, Shelly M., Miller, David S., Salani, Ritu, Moore, David H., Stehman, Frederick B.
Veröffentlicht 2016Text -
12
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study von Bishop, Erin A., Java, James J., Moore, Kathleen N., Spirtos, Nick M, Pearl, Michael L, Zivanovic, Oliver, Kushner, David M, Backes, Floor, Hamilton, Chad A., Geller, Melissa A., Hurteau, Jean, Mathews, Cara, Wenham, Robert M., Ramirez, Pedro T., Zweizig, Susan, Walker, Joan L.
Veröffentlicht 2017Text -
13
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients() von Fuh, Katherine C., Java, James J., Chan, John K., Kapp, Daniel S., Monk, Bradley J., Burger, Robert A., Young, Robert C., Alberts, David S., McGuire, William P., Markman, Maurie, Bell, Jeffrey, Ozols, Robert F., Armstrong, Deborah K., Aghajanian, Carol, Bookman, Michael A., Mannel, Robert S.
Veröffentlicht 2019Text -
14
Predictive Modeling for Determination of Microscopic Residual Disease at Primary Cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study von Horowitz, Neil S., Maxwell, G. Larry, Miller, Austin, Hamilton, Chad A., Rungruang, Bunja, Rodriguez, Noah, Richard, Scott D., Krivak, Thomas C., Fowler, Jeffrey M., Mutch, David G., Van Le, Linda, Lee, Roger B., Argenta, Peter, Bender, David, Tewari, Krishnansu S., Gershenson, David, Java, James J., Bookman, Michael A.
Veröffentlicht 2017Text -
15
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma von Rose, Peter G, Java, James J, Salani, Ritu, Geller, Melissa A, Alvarez, Angeles, Tewari, Krishnansu S, Bender, David P, Mutch, David G, Friedlander, Michael L, Van Le, Linda, Method, Michael W, Hamilton, Chad A, Lee, Roger B, Wenham, Robert M, Guntupalli, Saketh R, Markman, Maurie, Muggia, Franco M, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Copeland, Larry J
Veröffentlicht 2019Text